| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |